Description of the analysis of a wide range of volatile organic compounds in whole air samples collected during PEM-tropics A and B.

A large number of hydrocarbons, halocarbons, and organic nitrates were quantified in whole air samples acquired for the NASA-sponsored GTE missions PEM-Tropics A and B. The samples were collected in electro-polished stainless steel canisters from two aircraft while flying over the Pacific Basin. Two nominally identical multicolumn multidetector gas chromatographic analytical systems were employed. Whole air samples were also used as working and calibrated standards and were collected specifically for this purpose. This paper describes the analytical procedure employed during PEM-Tropics B. Minor differences in the PEM-Tropics A system will also be discussed. More than 3,900 samples were analyzed for 34 gases during PEM-Tropics A, over 4,500 samples were analyzed for 58 gases during PEM-Tropics B. An overview is presented of the collection, analysis, and quantification of whole air samples during the PEM-Tropics missions, along with an analysis of the analytical precision achieved during these missions.

Calcium channel antagonists: morbidity and mortality--what's the evidence?

Recent studies have shown an association between the use of calcium channel antagonists for the treatment of hypertension and an increased risk of myocardial infarction, gastrointestinal hemorrhage and cancer. The interpretation of the results of these studies and their application to clinical practice requires an understanding of study design constraints, conflicting results and limitations in extrapolating study findings to other dosage strengths, formulations or agents within the calcium channel antagonist class. A review and critique of these studies provides background information on the controversial subject of using calcium channel antagonists for the treatment of hypertension. Despite the limitations of these studies, clinicians may want to select other classes of agents, including diuretics and beta blockers, as first-line therapy until the morbidity and mortality effects related to the use of calcium channel antagonists are clearly known.

An assessment of the early management of spine problems and appropriateness of diagnostic imaging utilization.

Low back pain may affect up to 80% of all adults and is the second leading reason for physician visits in ambulatory medicine. Estimates for the annual direct medical costs for treating patients with back pain approach $25 million, despite the fact that it is a self-limited condition in at least 90% of patients with recovery occurring within 6 to 12 weeks. Recent scrutiny of health care delivery has produced numerous observations documenting a high variability in use of resources for medical conditions including low back pain, but few studies have attempted to examine the medical appropriateness of diagnostic and therapeutic decisions.

Chemically induced porphyria: prevention by prior treatment with phenobarbital.

The excessive induction of hepatic delta-aminolevulinic acid synthetase in rats after the administration of porphyria-inducing compounds is prevented by prior treatment with phenobarbital. Studies in vivo and in vitro indicate that phenobarbital prevents the induction of chemical porphyria by increasing the rate of detoxification of inducers by way of drug-metabolizing enzymes of the hepatic endoplasmic reticulum.